Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nichols

Showing results (961-970 of 973) with videos related to

Pageof 98
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
JAMA Oncology|April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical TrialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer|February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trialAnthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Nature Genetics|September 22, 2014
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glandsIlan Weinreb, Salvatore Piscuoglio, Luciano G Martelotto, et al.
Science Translational Medicine|January 10, 2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertensionYi-Yin Tai, Qiujun Yu, Ying Tang, et al.
The Lancet. Oncology|June 15, 2020
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensusHisham Mehanna, John C Hardman, Jared A Shenson, et al.
Science (New York, N.Y.)|January 23, 2025
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertensionLloyd D Harvey, Mona Alotaibi, Yi-Yin Tai, et al.
American Journal of Human Genetics|September 13, 2011
Translation initiator EIF4G1 mutations in familial Parkinson diseaseMarie-Christine Chartier-Harlin, Justus C Dachsel, Carles Vilariño-Güell, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Pageof 98

Showing results (961-970 of 973) with videos related to

Sort By:
Pageof 98
European Journal of Cancer (Oxford, England : 1990)|March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
JAMA Oncology|April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical TrialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer|February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trialAnthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Nature Genetics|September 22, 2014
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glandsIlan Weinreb, Salvatore Piscuoglio, Luciano G Martelotto, et al.
Science Translational Medicine|January 10, 2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertensionYi-Yin Tai, Qiujun Yu, Ying Tang, et al.
The Lancet. Oncology|June 15, 2020
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensusHisham Mehanna, John C Hardman, Jared A Shenson, et al.
Science (New York, N.Y.)|January 23, 2025
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertensionLloyd D Harvey, Mona Alotaibi, Yi-Yin Tai, et al.
American Journal of Human Genetics|September 13, 2011
Translation initiator EIF4G1 mutations in familial Parkinson diseaseMarie-Christine Chartier-Harlin, Justus C Dachsel, Carles Vilariño-Güell, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Pageof 98